Skip to content
ESSA Pharma
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisors
    • Careers
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Androgen Receptor
    • Aniten Compounds
    • Publications
  • News
  • Investors
    • Investor Info
    • Corporate Governance
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor Contact
    • Publications
    • SEC Regulatory Filings
  • Contact
ESSA PHARMA, INC. HAS BEGUN DEVELOPMENT OF A SECOND GENERATION ANITEN COMPOUND FOR THE TREATMENT OF HORMONE-DRIVEN CANCER

News

News Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Date Title
December 14, 2016

ESSA Pharma Provides Business Update and Announces Fourth Quarter and Year Ended September 30, 2016 Financial Results

November 21, 2016

ESSA SECURES US$10 MILLION TERM LOAN FROM SILICON VALLEY BANK

September 12, 2016

ESSA Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference

August 12, 2016

ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER JUNE 30, 2016

August 1, 2016

ESSA NAMES PETER VIRSIK AS EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER

May 13, 2016

ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED MARCH 31, 2016

March 21, 2016

ESSA PHARMA ANNOUNCES CLOSING OF US$5 MILLION PRIVATE PLACEMENT

March 21, 2016

ESSA PHARMA ANNOUNCES CLOSING OF A SECONDARY OFFERING

March 10, 2016

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

February 12, 2016

ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED DECEMBER 31, 2015

  • 1
  • 2
  • »
  • Home
  • Our Company
  • Executive Team
  • Board of Directors
  • Scientific Advisors
  • Careers
  • Pipeline
  • Expanded Access Policy
  • Androgen Receptor
  • Aniten Compounds
  • Publications
  • News
  • Press Releases
  • Investors
  • Corporate Governance
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor Contact
  • Contact
  • Locations & Inquiries
© ESSA Pharma, Inc. 2020. All rights reserved. Privacy Policy | Terms & Conditions | Code of Conduct